264 related articles for article (PubMed ID: 23643539)
1. A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.
Adam J; Yang M; Bauerschmidt C; Kitagawa M; O'Flaherty L; Maheswaran P; Özkan G; Sahgal N; Baban D; Kato K; Saito K; Iino K; Igarashi K; Stratford M; Pugh C; Tennant DA; Ludwig C; Davies B; Ratcliffe PJ; El-Bahrawy M; Ashrafian H; Soga T; Pollard PJ
Cell Rep; 2013 May; 3(5):1440-8. PubMed ID: 23643539
[TBL] [Abstract][Full Text] [Related]
2. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
Frezza C; Zheng L; Folger O; Rajagopalan KN; MacKenzie ED; Jerby L; Micaroni M; Chaneton B; Adam J; Hedley A; Kalna G; Tomlinson IP; Pollard PJ; Watson DG; Deberardinis RJ; Shlomi T; Ruppin E; Gottlieb E
Nature; 2011 Aug; 477(7363):225-8. PubMed ID: 21849978
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.
Ternette N; Yang M; Laroyia M; Kitagawa M; O'Flaherty L; Wolhulter K; Igarashi K; Saito K; Kato K; Fischer R; Berquand A; Kessler BM; Lappin T; Frizzell N; Soga T; Adam J; Pollard PJ
Cell Rep; 2013 Mar; 3(3):689-700. PubMed ID: 23499446
[TBL] [Abstract][Full Text] [Related]
4. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.
Bardella C; El-Bahrawy M; Frizzell N; Adam J; Ternette N; Hatipoglu E; Howarth K; O'Flaherty L; Roberts I; Turner G; Taylor J; Giaslakiotis K; Macaulay VM; Harris AL; Chandra A; Lehtonen HJ; Launonen V; Aaltonen LA; Pugh CW; Mihai R; Trudgian D; Kessler B; Baynes JW; Ratcliffe PJ; Tomlinson IP; Pollard PJ
J Pathol; 2011 Sep; 225(1):4-11. PubMed ID: 21630274
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism.
O'Flaherty L; Adam J; Heather LC; Zhdanov AV; Chung YL; Miranda MX; Croft J; Olpin S; Clarke K; Pugh CW; Griffiths J; Papkovsky D; Ashrafian H; Ratcliffe PJ; Pollard PJ
Hum Mol Genet; 2010 Oct; 19(19):3844-51. PubMed ID: 20660115
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis.
Ashrafian H; O'Flaherty L; Adam J; Steeples V; Chung YL; East P; Vanharanta S; Lehtonen H; Nye E; Hatipoglu E; Miranda M; Howarth K; Shukla D; Troy H; Griffiths J; Spencer-Dene B; Yusuf M; Volpi E; Maxwell PH; Stamp G; Poulsom R; Pugh CW; Costa B; Bardella C; Di Renzo MF; Kotlikoff MI; Launonen V; Aaltonen L; El-Bahrawy M; Tomlinson I; Pollard PJ
Cancer Res; 2010 Nov; 70(22):9153-65. PubMed ID: 20978192
[TBL] [Abstract][Full Text] [Related]
7. UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.
Yang Y; Valera VA; Padilla-Nash HM; Sourbier C; Vocke CD; Vira MA; Abu-Asab MS; Bratslavsky G; Tsokos M; Merino MJ; Pinto PA; Srinivasan R; Ried T; Neckers L; Linehan WM
Cancer Genet Cytogenet; 2010 Jan; 196(1):45-55. PubMed ID: 19963135
[TBL] [Abstract][Full Text] [Related]
8. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production.
Hooftman A; Peace CG; Ryan DG; Day EA; Yang M; McGettrick AF; Yin M; Montano EN; Huo L; Toller-Kawahisa JE; Zecchini V; Ryan TAJ; Bolado-Carrancio A; Casey AM; Prag HA; Costa ASH; De Los Santos G; Ishimori M; Wallace DJ; Venuturupalli S; Nikitopoulou E; Frizzell N; Johansson C; Von Kriegsheim A; Murphy MP; Jefferies C; Frezza C; O'Neill LAJ
Nature; 2023 Mar; 615(7952):490-498. PubMed ID: 36890227
[TBL] [Abstract][Full Text] [Related]
9. Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects.
Tyrakis PA; Yurkovich ME; Sciacovelli M; Papachristou EK; Bridges HR; Gaude E; Schreiner A; D'Santos C; Hirst J; Hernandez-Fernaud J; Springett R; Griffiths JR; Frezza C
Cell Rep; 2017 Oct; 21(4):1036-1047. PubMed ID: 29069586
[TBL] [Abstract][Full Text] [Related]
10. Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.
Bardella C; Olivero M; Lorenzato A; Geuna M; Adam J; O'Flaherty L; Rustin P; Tomlinson I; Pollard PJ; Di Renzo MF
Mol Cell Biol; 2012 Aug; 32(15):3081-94. PubMed ID: 22645311
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite.
Perez M; Bak DW; Bergholtz SE; Crooks DR; Arimilli BS; Yang Y; Weerapana E; Linehan WM; Meier JL
J Biol Chem; 2020 Sep; 295(39):13410-13418. PubMed ID: 32820045
[TBL] [Abstract][Full Text] [Related]
12. A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer.
Yang Y; Valera V; Sourbier C; Vocke CD; Wei M; Pike L; Huang Y; Merino MA; Bratslavsky G; Wu M; Ricketts CJ; Linehan WM
Cancer Genet; 2012; 205(7-8):377-90. PubMed ID: 22867999
[TBL] [Abstract][Full Text] [Related]
13. mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma.
Drusian L; Nigro EA; Mannella V; Pagliarini R; Pema M; Costa ASH; Benigni F; Larcher A; Chiaravalli M; Gaude E; Montorsi F; Capitanio U; Musco G; Frezza C; Boletta A
Cell Rep; 2018 Jul; 24(5):1093-1104.e6. PubMed ID: 30067967
[TBL] [Abstract][Full Text] [Related]
14. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.
Adam J; Hatipoglu E; O'Flaherty L; Ternette N; Sahgal N; Lockstone H; Baban D; Nye E; Stamp GW; Wolhuter K; Stevens M; Fischer R; Carmeliet P; Maxwell PH; Pugh CW; Frizzell N; Soga T; Kessler BM; El-Bahrawy M; Ratcliffe PJ; Pollard PJ
Cancer Cell; 2011 Oct; 20(4):524-37. PubMed ID: 22014577
[TBL] [Abstract][Full Text] [Related]
15. Fumarate hydratase deficiency and cancer: activation of hypoxia signaling?
Ratcliffe PJ
Cancer Cell; 2007 Apr; 11(4):303-5. PubMed ID: 17418405
[TBL] [Abstract][Full Text] [Related]
16. Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report.
Chan MMY; Barnicoat A; Mumtaz F; Aitchison M; Side L; Brittain H; Bates AWH; Gale DP
BMC Med Genet; 2017 Jul; 18(1):79. PubMed ID: 28747166
[TBL] [Abstract][Full Text] [Related]
17. Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.
Ueno D; Vasquez JC; Sule A; Liang J; van Doorn J; Sundaram R; Friedman S; Caliliw R; Ohtake S; Bao X; Li J; Ye H; Boyd K; Huang RR; Dodson J; Boutros P; Bindra RS; Shuch B
Oncotarget; 2022; 13():1054-1067. PubMed ID: 36128328
[TBL] [Abstract][Full Text] [Related]
18. Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells.
Zheng L; MacKenzie ED; Karim SA; Hedley A; Blyth K; Kalna G; Watson DG; Szlosarek P; Frezza C; Gottlieb E
Cancer Metab; 2013 Mar; 1(1):12. PubMed ID: 24280230
[TBL] [Abstract][Full Text] [Related]
19. Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.
Shyu I; Mirsadraei L; Wang X; Robila V; Mehra R; McHugh JB; Chen YB; Udager AM; Gill AJ; Cheng L; Amin MB; Lin O; Smith SC
Cancer Cytopathol; 2018 Dec; 126(12):992-1002. PubMed ID: 30339328
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma.
Yang Y; Lane AN; Ricketts CJ; Sourbier C; Wei MH; Shuch B; Pike L; Wu M; Rouault TA; Boros LG; Fan TW; Linehan WM
PLoS One; 2013; 8(8):e72179. PubMed ID: 23967283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
